Magnesium Research

This systematic review evaluated the effects of magnesium supplementation on self-reported anxiety and sleep quality in adults. The authors searched multiple databases and identified studies examining oral magnesium supplementation with validated outcome measures for anxiety or sleep.

The review found that magnesium supplementation demonstrated beneficial effects on both anxiety symptoms and sleep quality across multiple studies. However, the evidence was characterized by significant heterogeneity in study populations, magnesium forms, dosages, and duration of supplementation.

The authors conclude that while preliminary evidence supports magnesium's role in anxiety and sleep management, more rigorous randomized controlled trials with standardized protocols are needed to establish definitive recommendations.

This umbrella meta-analysis synthesized evidence from multiple previous meta-analyses examining the effect of magnesium supplementation on blood pressure in randomized controlled trials. By aggregating findings across meta-analyses, this approach provides a higher level of evidence than individual studies or single meta-analyses.

The pooled analysis found that magnesium supplementation significantly reduced both systolic blood pressure (SBP) and diastolic blood pressure (DBP) compared to placebo. The magnitude of reduction, while statistically significant, was modest but clinically meaningful, particularly for individuals with hypertension or prehypertension.

The authors conclude that magnesium supplementation represents a safe and effective adjunct strategy for blood pressure management, with the strongest evidence supporting benefits in hypertensive individuals. The consistency of findings across multiple meta-analyses strengthens confidence in these conclusions.

This systematic review and meta-analysis examined 7 randomized clinical trials with 325 adults (aged 20-60) diagnosed with depressive disorder. It assessed the effect of magnesium supplementation compared to placebo or control on depression severity.

Key findings:

• Significant reduction in depression scores with magnesium supplementation (SMD: -0.919, 95% CI: -1.443 to -0.396, p = 0.001)
• Benefits observed across different depression assessment scales
• Effect size was large, suggesting clinically meaningful improvement

Clinical implications:

Supports magnesium supplementation as a beneficial adjunct for depression management, though larger high-quality trials are needed to establish definitive clinical guidelines.

This systematic review comprehensively examined the relationship between magnesium and sleep health, including both observational studies on magnesium status and interventional trials of supplementation. The authors analyzed evidence from multiple study types to understand magnesium's role in sleep regulation.

The review found consistent associations between low serum magnesium levels and poor sleep quality in observational studies. Intervention studies generally showed that magnesium supplementation improved subjective sleep quality, sleep efficiency, and sleep onset latency, with effects most pronounced in populations with low baseline magnesium or sleep disturbances.

Mechanistically, magnesium appears to support sleep through GABA receptor modulation, melatonin regulation, and reduction of cortisol. The authors conclude that magnesium plays an important role in sleep health and supplementation may be beneficial, especially for those with inadequate intake or deficiency.

This meta-analysis pooled 17 randomized controlled trials with 889 participants (mean age 46, 62.5% female) to assess the effect of oral magnesium supplementation on serum inflammatory markers compared to placebo.

Key findings:

• Magnesium significantly decreased serum C-reactive protein (CRP)
• Magnesium significantly increased nitric oxide (NO) levels
• Additional reductions observed in plasma fibrinogen, TNF-ligand superfamily member 13B, IL-1, and ST2 protein
• Trials had generally low risk of bias

Clinical implications:

These results support magnesium supplementation as a strategy for reducing systemic inflammation, with CRP and NO being the most robustly affected markers across studies.

This systematic review and meta-analysis examined 3 RCTs with 151 older adults to evaluate whether oral magnesium supplementation improves insomnia outcomes compared to placebo.

Key findings:

• Sleep onset latency decreased by 17.36 minutes with magnesium vs placebo (95% CI: -27.27 to -7.44, p = 0.0006)
• Total sleep time showed a non-significant increase of 16.06 minutes
• All included trials had moderate-to-high risk of bias
• Evidence quality rated low to very low by GRADE assessment

Clinical implications:

Despite limited evidence quality, the meaningful reduction in sleep onset latency and magnesium's favorable safety profile, low cost, and wide availability make it a reasonable option for older adults with insomnia.

This systematic review examined 18 studies investigating the relationship between magnesium supplementation and anxiety.

Key findings:

• Suggestive evidence for anxiolytic effects of magnesium
• Effects most pronounced in individuals with:
• Pre-existing anxiety
• Premenstrual syndrome
• Mild hypertension
• Combination with vitamin B6 may enhance effects
• Generally well-tolerated with few side effects

Limitations noted:

• Heterogeneous study designs
• Variable magnesium forms and doses
• Many studies in specific populations

Conclusion:

While evidence is suggestive rather than definitive, magnesium shows promise for anxiety management, particularly in those with suboptimal status.

This meta-analysis examined 9 cross-sectional studies involving 31,712 participants to assess the relationship between magnesium intake and depression risk.

Key findings:

• Significant inverse association between magnesium intake and depression risk
• Higher magnesium intake associated with lower depression rates
• Association was consistent across different populations
• Effect was dose-dependent

Mechanism proposed:

• Magnesium's role in NMDA receptor regulation
• Effects on HPA axis and stress response
• Influence on inflammatory pathways
• GABA modulation

Clinical implications:

Supports optimizing magnesium intake as part of mental health support, though prospective trials are needed to establish causation.

This double-blind, placebo-controlled trial examined the effect of magnesium supplementation on sleep quality in 46 elderly adults with primary insomnia.

Key findings:

• Sleep quality index improved significantly (p < 0.001)
• Sleep time increased
• Serum melatonin levels increased
• Cortisol levels decreased
• Sleep efficiency improved

Protocol:

• 500mg magnesium daily for 8 weeks
• Elderly participants (60-75 years)
• Measured both subjective and objective markers

Clinical significance:

Provides strong evidence for magnesium's role in sleep regulation, particularly in populations at high risk for deficiency.